Fibrosis: all 1,270 studies
Page 7 of 13. Open to participants first (276), then studies with results posted, then the rest; newest registration first within each.
- Natural History of Non Alcoholic Fatty Liver Disease and Predictors of Advanced FibrosisWithdrawnNCT05050721
- Use of CADISS Medical Device to Facilitate Dissection of Epidural Fibrosis in Revision Spine SurgeryCompletedNCT05016739Not applicable
- Sodium-glucose Linked Transporter 2 (SGLT-2) Inhibitors in Recurrent Ascites: a Pilot RCTStatus unknownNCT05014594Phase 2
- Empagliflozin in Diuretic Refractory AscitesCompletedNCT05013502Phase 1
- Saroglitazar Magnesium for the Treatment of Nonalcoholic Steatohepatitis With FibrosisCompletedNCT05011305Phase 2
- Growth Hormone as a Model for Reversible Activation of Adipose Tissue FibrosisActive, not recruitingNCT04998500Not applicable
- Endoscopic Resection of Early Esophageal Tumors in the Context of Cirrhosis or Portal HypertensionCompletedNCT04994548
- Fractional Excretion of Urea for the Differential Diagnosis of Acute Kidney Injury in CirrhosisStatus unknownNCT04986137
- Safety of Anticoagulant Therapy After Endoscopic TreatmentCompletedNCT04976543Phase 4
- Phase 1 Study of GSK3228836 Pharmacokinetics in Participants With Hepatic ImpairmentCompletedNCT04971928Phase 1
- Prevalence, Clinical Features and Risk Factors of Cirrhotic Cardiomyopathy Assessed by Two-dimensional Speckle Tracking ImagingStatus unknownNCT04969055
- Citrate Pharmacokinetics in Critically Ill Liver Failure Patients Receiving CRRTCompletedNCT04959110Not applicable
- A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension (MAESTRO-NAFLD-OLE)Active, not recruitingNCT04951219Phase 3
- Pilot Study of the Predictive Value of TREM1 Expression and Activation in Inflammation and Radio-induced Mammary FibrosisStatus unknownNCT04948840Not applicable
- Eye Movement Testing for Diagnosing Encephalopathy in Patients With Liver DiseaseTerminatedNCT04940416
- Evaluation of the Vaccination Coverage of Cirrhotic Patients Followed in the General Hospitals in France in 2021CompletedNCT04939350
- Cohort Follow-up of Survivors of Hospitalization for COVID-19 During the 2nd Wave of the Epidemic in FranceStatus unknownNCT04934202
- A 3-part Study to Evaluate Safety, Tolerability, Food Effect and Drug-drug Interactions of RXC007 in Healthy VolunteersCompletedNCT04931147Phase 1
- The Management of Surgical Scars Around Knee After Pediatric Orthopedic Surgery: an Observational, Case-control StudyStatus unknownNCT04928443
- Antimicrobial Resistance in Cirrhotic PatientsStatus unknownNCT04915573
- Mineralocorticoid Receptor Antagonist and Pulmonary Fibrosis in COVID-19.Status unknownNCT04912011Phase 4
- Angiotensin II in Liver TransplantationActive, not recruitingNCT04901169Phase 2/3
- Safety, Tolerability, and Efficacy of AXA1125 in NASH With FibrosisStatus unknownNCT04880187Phase 2
- A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 )Active, not recruitingNCT04849728Phase 3
- Avatrombopaq In Patients With CirrhosisStatus unknownNCT04845659Phase 4
- Serum Selenium and Zinc Levels in Non-alcoholic Fatty Liver Disease PatientsCompletedNCT04834063
- Evaluation of Minimal Hepatic Encephalopathy in Patients With Cirrhosis and Portal HypertensionCompletedNCT04807803Not applicable
- Decompensation of Cirrhosis and Iron MetabolismCompletedNCT04807023
- Risk Stratification of Hepatocarcinogenesis Using a Deep Learning Based Clinical, Biological and Ultrasound Model in High-risk PatientsCompletedNCT04802954Not applicable
- Urethral Stricture After Transurethral Resection of the Prostate/Bladder: a Prospective Study of Risk FactorsStatus unknownNCT04795570
- Acute-On-Chronic Liver Failure In Cirrhotic PatientsCompletedNCT04790435
- Assessment Of Lipid Profile In Cirrhotic PatientsCompletedNCT04788173
- The vPPG-detecting Software Guided Management of Cirrhotic Portal HypertensionStatus unknownNCT04786782
- Timing of Endoscopic Intervention for Acute Variceal Hemorrhage: an RCTCompletedNCT04786743Not applicable
- A Study of Single Ascending Dose of LEM-S401 in Healthy ParticipantsCompletedNCT04707131Phase 1
- A Healthy Volunteer Study of PBI-4050CompletedNCT04695041Phase 1
- Elective Umbilical Hernia Repair in Patients With CirrhosisStatus unknownNCT04687579Not applicable
- Assessment of the Correlation Between Serum Levels of Adropin and Degree of Severity of Chronic Liver DiseaseStatus unknownNCT04660409Not applicable
- Non-Pharmaceutical Intervention for Cirrhotic Cramps Reduction: The NICCles TrialCompletedNCT04650295Not applicable
- Epigenetics in Lupus NephritisStatus unknownNCT04648059
- Apixaban, Warfarin and Aspirin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy（ESAWAAPT）CompletedNCT04645550Phase 4
- EUS Share-wave in Patients With Liver CirrhosisCompletedNCT04644055
- Defining the Mechanisms Underlying Adrenal Insufficiency in CirrhosisCompletedNCT04642391
- A Study to Evaluate the Drug Levels, Safety, and Tolerability of BMS-986036 in Participants With Normal Liver Function and Participants With Moderate and Severe Liver ImpairmentCompletedNCT04634149Phase 1
- Quantitative MRI Imaging in Diffuse Liver DiseasesStatus unknownNCT04626492
- Etiopathogenesis of Anemia in Chronic Liver DiseaseStatus unknownNCT04622449
- Volatile Organic Compounds for the Assessment of Liver DiseaseCompletedNCT04620538
- Quantifying Body Composition and Liver Disease in Children Using Free-Breathing MRI and MRECompletedNCT04591106
- TD-1058 First-In-Human Study in Healthy Subjects and Subjects With Idiopathic Pulmonary FibrosisTerminatedNCT04589260Phase 1
- Comparison of PFS and ART in Adhesive Capsulitis in Diabetic PatientsCompletedNCT04561310Not applicable
- Usefulness of Cardiopulmonary Exercise Testing for Cardiovascular Risk Estimation and Frailty Assessment in Liver Transplant CandidatesCompletedNCT04543825
- Endoscopic and Microbiological Assessment of the Effect of Carvedilol Combined With Berberine on GOV in CirrhosisStatus unknownNCT04543643Phase 3
- Orphenadrine Versus Baclofen in Treatment of Muscle Cramps in Cirrhotic PatientsTerminatedNCT04509336Not applicable
- Screening for Alcohol-related Cognitive Impairments in Cirrhotic PatientsTerminatedNCT04490330
- Predicting the Progression to Chronic Fibrosis of Lung Lesions Related to Covid-19 Infection From Chest CT ImagesStatus unknownNCT04483752Not applicable
- Efficacy and Safety of Tigerase® vs. Pulmozyme® in Patients With Cystic FibrosisCompletedNCT04468100Phase 3
- Screening for NAFLD-related Advanced Fibrosis in High Risk Population in Diabetology.CompletedNCT04435054Not applicable
- Evaluation of Advanced US Tools in Assessing Allograft ComplicationsCompletedNCT04423458
- Prospective Cohort Study of Disease and Outcomes in CirrhosisStatus unknownNCT04422223
- COVID19-FOIE National ObservatoryCompletedNCT04375670
- Periodontal Therapy and Oral-gut-hepatic Axis Cirrhosis: a Randomized Controlled TrialStatus unknownNCT04330469Not applicable
- Comparing Ascites Relief In Two Standard Treatments: Large Volume Paracentesis Vs. Early Tips Using Viatorr Controlled Expansion StentsCompletedNCT04315571Not applicable
- Refractory Ascites in Patients With Liver Cirrhosis, and the Potential Treatment With 48 Hours Infusion of Ularitide.TerminatedNCT04311489Phase 2
- Genomic Resources for Enhancing Available Therapies (GREAT1.0) StudySuspendedNCT04306939
- Zinc Status and Growth in Cystic FibrosisCompletedNCT04302428
- Two Different Physiotherapy Programs in Lymphedema Following Head and Neck Cancer TreatmentCompletedNCT04286698Not applicable
- Endoscopic Bariatric Therapy in NASH CirrhosisStatus unknownNCT04281303
- ADAMTS-13 and Von Willebrand Factor Levels and Activities in Children With Cirrhosis and/or Portal HypertensionCompletedNCT04267406
- Characterization of Methylation Patterns in Hepatocellular CarcinomaTerminatedNCT04264754
- Trial of Pirfenidone to Prevent Progression in Chronic Kidney DiseaseStatus unknownNCT04258397Phase 2
- Laparoscopic Splenectomy and Azygoportal Disconnection With Intraoperative Endoscopic Variceal LigationCompletedNCT04244487Not applicable
- Frailty in Patients With Cirrhosis: Prognostic Value of the Phase Angle in Hospitalized Patients and Effect of Multifactorial InterventionCompletedNCT04243148Not applicable
- Screening of Liver Fibrosis Using Blood Tests in Patients With Type 2 Diabetes MellitusCompletedNCT04232293Not applicable
- CAREGIVER: A Trial to Improve the Burden and Distress of Caring for Persons With Decompensated CirrhosisCompletedNCT04205396Not applicable
- A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Non Alcoholic Fatty Liver Disease PatientsCompletedNCT04197479Phase 3
- GastrOesophageal Varices After Sustained Virological ResponseStatus unknownNCT04191018
- Chemotherapy and Liver Cirrhosis in Frequently-associated CancersTerminatedNCT04179773
- Anti-fungal Strategies in Acute-on-Chronic Liver Failure PatientsCompletedNCT04157465Not applicable
- A Phase III Study to Evaluate Efficacy and Safety of TG-2349 in Combination With DAG181 and RBV for HCV Type I PatientsCompletedNCT04155515Phase 3
- Doxycycline for the Prevention of Spontaneous Bacterial PeritonitisCompletedNCT04153604
- Alcoholic Hepatitis in Latin-America: A Prospective and Multicentric Study (AH-LATIN).Status unknownNCT04142723
- MERTK Signalling in Monocytes/Macrophages in Patients With Liver DiseaseCompletedNCT04116242
- Invasive Fungal Infections in Severe Alcohol-associated HepatitisStatus unknownNCT04103840
- Ultrasonography for Nutritional Assesment in Cirrhotic PatientsStatus unknownNCT04099875
- EUS-guided Combined Therapy Versus Beta Blocker Therapy in Primary Prophylaxis o GOV II and IGV IStatus unknownNCT04075760Not applicable
- Impact of Nonselective Beta-blocker on Acute Kidney Injury in Cirrhotic Patients With Esophageal VaricesStatus unknownNCT04074473Phase 4
- A Study of Oryz-Aspergillus Enzyme and Pancreatin Tablet in Patients With Cirrhosis and MalnutritionStatus unknownNCT04057326Not applicable
- Angiotensin 2 for Hepatorenal SyndromeWithdrawnNCT04048707Phase 2
- Effect of Non-alcoholic Beer in CirrhosisCompletedNCT04041115Not applicable
- Effects of Interval Training Effects on Cardiac FibrosisCompletedNCT04038723Not applicable
- Liver Resection ModelingStatus unknownNCT04023136Not applicable
- EXplanted LIver and Ex-vivo Pancreatic Specimen Evaluation by 7 TESLA MRIStatus unknownNCT04012021Not applicable
- Comparing SonoVue With Sonazoid Using CEUS-LIRADS in HCCStatus unknownNCT04006275Phase 3
- Healthy Volunteer Study Comparing Tablet and Capsule FormulationsWithdrawnNCT04001998Phase 1
- The Effect of Ramipril in Suppressing ST2 Expression in Rheumatic Mitral Stenosis PatientsStatus unknownNCT03991910Phase 3
- Cirrhotic Patients With Septic ShockCompletedNCT03987048
- Validation of the LiverFASt Test and the Associated Fibrosis Staging Scores Compared to Liver Tissue Pathology Via Liver BiopsyWithdrawnNCT03980912
- Identification of Biomarkers Related to Liver Fibrosis as New Therapeutic TargetsCompletedNCT03979417
- Telehealth Intervention in CirrhoticsCompletedNCT03969186Not applicable
- Data Collection and Identification of Infection-responsible Bacterial Resistances in Cirrhotic PatientsCompletedNCT03965260